(Q35814410)

10 August 2017

1 reference

title

Towards the pharmacotherapy of hairy cell leukaemia (English)

1 reference

10 August 2017

0 references

1 reference

Francesco Lauria

1

1 reference

PubMed ID

15212603

10 August 2017

Francesco Forconi

series ordinal

2

1 reference

PubMed ID

15212603

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

7

1 reference

10 August 2017

1523-1533

1 reference

Splenectomy and treatments of historical interest

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Erythrokinetic studies in hairy-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Interferon in the treatment of hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Fludarabine therapy in hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Newer purine analogues for the treatment of hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Immunobiological treatments of hairy-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Second malignancies in hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Risk of second cancer in patients with hairy cell leukemia: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1523

10.1517/14656566.5.7.1523

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15212603